CDK12/13 ligand 1
Product Specifications
CAS Number
2244986-40-9
Target
CDK
Related Pathways
Cell Cycle/Checkpoint
Bioactivity
ALK-IN-29 (compound 4c) exhibits notable inhibitory activity against tyrosine kinases such as ALK, CDK2/CyclinE1, and FAK, with the strongest inhibition observed against ALK kinase, showing a 40.63% inhibition rate at a concentration of 10 ?M. ALK-IN-29 is useful for cancer research.
Smiles
N(C(NCC1=CC=CC=C1)=O)([C@H]2CC[C@H](NC3=CC=C(C#N)C=N3)CC2)C4=CC=C(Br)C=C4
Molecular Formula
C26H26BrN5O
Molecular Weight
504.42
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS643022-01 0.2 mL
TOPBP1, ID (S1138) (TOPBP1, KIAA0259, DNA topoisomerase 2-binding protein 1, DNA topoisomerase II-beta-binding protein 1, DNA topoisomerase II-binding protein 1)
Ask
View Details 
MBS643022-02 5x 0.2 mL
TOPBP1, ID (S1138) (TOPBP1, KIAA0259, DNA topoisomerase 2-binding protein 1, DNA topoisomerase II-beta-binding protein 1, DNA topoisomerase II-binding protein 1)
Ask
View Details 
MBS2065821-01 0.1 mL
FITC-Linked Polyclonal Antibody to Endoplasmic Reticulum Protein 29 (ERP29)
Ask
View Details MBS2065821-02 0.2 mL
FITC-Linked Polyclonal Antibody to Endoplasmic Reticulum Protein 29 (ERP29)
Ask
View Details MBS2065821-03 0.5 mL
FITC-Linked Polyclonal Antibody to Endoplasmic Reticulum Protein 29 (ERP29)
Ask
View Details